Mechanisms of Disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease
- 1 April 2005
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Cardiovascular Medicine
- Vol. 2 (4) , 209-216
- https://doi.org/10.1038/ncpcardio0158
Abstract
Changes in the composition of cardiac tissue develop in arterial hypertension and lead to structural remodeling of the myocardium. Structural remodeling is the consequence of a number of pathologic processes, mediated by mechanical, neurohormonal and cytokine routes, occurring in the cardiomyocyte and the noncardiomyocyte compartments of the heart. One of these processes is related to the disruption of the equilibrium between the synthesis and degradation of collagen type I and III molecules, which results in an excessive accumulation of collagen type I and III fibers in the interstitium and the perivascular regions of the myocardium. The clinical relevance of ventricular fibrosis is that it might contribute to the increased cardiac risk of patients with hypertensive heart disease. This review focuses on the mechanisms of hypertensive ventricular fibrosis and its clinical consequences. In addition, we discuss the noninvasive methods for the diagnosis of cardiac fibrosis and the therapeutic strategies aimed to promote its reduction.Keywords
This publication has 54 references indexed in Scilit:
- Downregulation of Matrix Metalloproteinases and Collagens and Suppression of Cardiac Fibrosis by Inhibition of the ProteasomeHypertension, 2004
- Profibrotic Effects of Angiotensin II in the HeartHypertension, 2004
- Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve diseaseHeart, 2004
- AT1 Receptor Blocker Added to ACE Inhibitor Provides Benefits at Advanced Stage of Hypertensive Diastolic Heart FailureHypertension, 2004
- Pressure-Independent Effects of Angiotensin II on Hypertensive Myocardial FibrosisHypertension, 2004
- Biochemical Assessment of Myocardial Fibrosis in Hypertensive Heart DiseaseHypertension, 2001
- Chronic AT 1 Blockade Stimulates Extracellular Collagen Type I Degradation and Reverses Myocardial Fibrosis in Spontaneously Hypertensive RatsHypertension, 2000
- Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertensionThe American Journal of Cardiology, 1993
- Collagen deposition and the reversal of coronary reserve in cardiac hypertrophy.Hypertension, 1992
- Epidemiologic Features of Chronic Atrial FibrillationNew England Journal of Medicine, 1982